American Society of Gene and Cell Therapy (ASGCT) Symposium: Extending Genetically Modified T cells to CD19-Negative Hematologic Malignancies
Catherine M. Bollard, Children’s Natl. Med. Ctr., George Washington Univ.
Saar Gill, Univ. of Pennsylvania
- Catherine M. Bollard, Children’s Natl. Med. Ctr., George Washington Univ., Overcoming TGF-β as an immune evasion strategy
- Terry J. Fry, NCI, NIH, Potential for improving durability of CAR-induced remissions
- Saar Gill, Univ. of Pennsylvania, CAR T cells for myeloid malignancies
- Maksim Mamonkin, Baylor Col. of Med., Targeting T cell malignancies with CAR T cells